Despite Economic Uncertainty, 95% of Entrepreneurs Surveyed Are Confident Their Business Will Grow This Year
Entrepreneurs are pursuing fundraising, strategic transactions and AI investments as the market outlook improves and talent becomes easier to access
NEW YORK, June 3, 2025 /PRNewswire/ -- Despite 43% of entrepreneurs saying the economy is hurting their business, 95% remain confident in their success over the next year, according to new research from Ernst & Young LLP (EY US).
The EY Entrepreneur Ecosystem Barometer is a biannual study that surveyed 500 established entrepreneurs with $1 million or more in annual revenue to assess their business outlook and strategies.
When asked to choose what factors threatened their ability to be successful, entrepreneurs reported economic uncertainty (interest rates, inflation and tariffs), as well as regulatory or policy changes, as their leading concerns (38% each). These two factors together illustrate how overall unpredictable the current market has become due to policy choices and the challenges it creates for entrepreneurs.
Despite these concerns, entrepreneurs have an optimistic outlook for their business's ability to succeed. In fact, 73% of entrepreneurs report they've experienced revenue growth this year compared with last year, of which 29% report growth of 20% or higher.
"Entrepreneurs are the backbone of the US economy, so their optimism offers a powerful indicator about what's ahead for 2025. Based on our EY survey, despite economic uncertainty, entrepreneurs are forging ahead, remain resilient and continue to drive growth," said Anna Horndahl, EY Americas Entrepreneur Of The Year™ Co-director and an Assurance partner at EY US.
In the first EY Entrepreneur Ecosystem Barometer (November 2024) 76% of respondents reported revenue growth over the past year.
This optimism extends beyond individual performance. Entrepreneurs also foresee broad market improvement, with 77% anticipating the US economy will be stronger a year from now (April 2026), a slight decrease from 82% in all 2024.
Entrepreneurs chase capital and deals to fuel growth
This confidence is especially visible when considering the volatility that occurred in fundraising and strategic transactions (initial public offerings (IPOs), mergers and acquisitions (M&A), private sale, etc.) over the past six months.
While 95% of entrepreneurs planned to raise capital over the next 18 to 24 months (vs. 91% in fall 2024), only 19% aimed to raise $10 million or more, compared with 30% in fall 2024. Reporting the origins of capital funding, only 36% said they took on debt, a steep drop from 45% in fall 2024. These factors show entrepreneurs are relying less on external capital, signaling growing business strength.
In the fall of 2024, 72% of entrepreneurs were considering a strategic transaction, with 33% in early planning. Just six months later, that rose to 81%, with 51% now in early stages — showing a sharp increase in deal interest at the time. Only 3% said they had no plans for a transaction, down from 12% in fall 2024.
When asked to choose the reasons why they were seeking a strategic transaction, respondents were split fairly evenly:
19% to gain access to new markets/customers
18% to secure additional capital or financial resources
17% to acquire new technology, talent or capabilities
16% to achieve economies of scale or operational efficiencies
15% to exit the business or transition to a new venture
14% to address competitive pressures or industry consolidation
Entrepreneurs turn to AI to boost workforce performance
Entrepreneurs view artificial intelligence (AI) as key to boosting competitiveness. When asked how they're building resilience, 40% cited investing in automation and AI — the top strategy — followed by enhancing employee retention strategies (35%).
Similarly, when asked where they would invest their budget the most over the next year, entrepreneurs placed AI and machine learning technologies in their top three priorities (42%), with re-skilling and training programs for existing employees (39%) and talent identification and recruitment (36%) following closely.
Notably, female entrepreneurs were placing greater priority on re-skilling their existing teams, with 47% noting that it was one of their top three budget priorities, compared with 39% of all respondents.
Entrepreneurs said AI was shaping workforce strategy by helping hire talent (34%), reducing headcount while assisting with recruitment (28%), and boosting productivity without changing staff levels (22%).
Only 2% weren't using AI in workforce decisions, underscoring its growing role in talent management — possibly explaining why 63% say finding qualified talent is now easier.
Methodology
Wakefield Research conducted the EY Entrepreneur Ecosystem Barometer survey among 500 established entrepreneurs for a representative read of the market (defined as entrepreneurs at organizations with $1 million or more in annual revenue) between March 31 and April 11, using an email invitation and an online survey.
The full survey and more information about the EY Entrepreneur Ecosystem Barometer can be found here.
EY | Shape the future with confidenceEY is building a better working world by creating new value for clients, people, society and the planet, while building trust in capital markets.
Enabled by data, AI and advanced technology, EY teams help clients shape the future with confidence and develop answers for the most pressing issues of today and tomorrow.
EY teams work across a full spectrum of services in assurance, consulting, tax, strategy and transactions. Fueled by sector insights, a globally connected, multidisciplinary network and diverse ecosystem partners, EY teams can provide services in more than 150 countries and territories.
All in to shape the future with confidence.
EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients. Information about how EY collects and uses personal data and a description of the rights individuals have under data protection legislation are available via ey.com/privacy. EY member firms do not practice law where prohibited by local laws. For more information about our organization, please visit ey.com.
Ernst & Young LLP is a client-serving member firm of Ernst & Young Global Limited operating in the US.
© 2025 Ernst & Young LLP.All Rights Reserved.
CONTACT: Maggie Bower, Maggie.Bower@ey.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/despite-economic-uncertainty-95-of-entrepreneurs-surveyed-are-confident-their-business-will-grow-this-year-302468851.html
SOURCE EY
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 minutes ago
- Yahoo
NanoHive Medical Sublicenses DirectSync's Piezoelectric Patents to Explore Development of Hive™ Soft Titanium® 3D Printed Spine Interbody Fusion "Smart Implant"
BOSTON, June 10, 2025 /PRNewswire/ -- NanoHive Medical, LLC, a leading innovative 3D printed spinal implant technology company is pleased to announce that the company has secured the exclusive sublicense of DirectSync Surgical's piezoelectric implantable sensor technology for the field of spinal fusion. DirectSync Surgical had licensed the technology from the University of Kansas. NanoHive is exploring the advancement of successful proof-of-concept research to potentially develop bone stimulating and remote monitoring/data collection sensor technology housed in the company's highly innovative spinal interbody fusion device lattice which is currently commercialized in the company's Hive™ Soft Titanium® portfolio of 3D printed spinal interbody fusion devices. In October 2023, the company reported the initiation of a research collaboration with DirectSync Surgical. Based on the preliminary research generated, the company ascertained that their proprietary rhombic dodecahedron lattice technology was uniquely capable of transferring significant energy from the encapsulated piezoelectric sensor. The company is currently in the process of working with the US Food and Drug Administration (FDA) on the transfer of the Breakthrough Device Designation from DirectSync to NanoHive. Patrick O'Donnell, President & CEO of NanoHive stated, "NanoHive's Soft Titanium® technology is the ideal interbody fusion implant to deliver a sensor with data collection and bone stimulation capability. The company is excited about the prospect of leading the way with the development of a technological leap in the interbody fusion device category. Our view of the future of innovation in spine devices emphasizes that new technologies must demonstrate an improvement to patient virtual care and clinical outcomes as well as connectivity with enabling surgical technologies and artificial intelligence. These advancements must also deliver cost-efficiencies to the various stakeholders involved in the spine patient's episode-of-care. More meaningful and frequent data collection that can ultimately be utilized as a predictive tool will be essential to this vision." About NanoHive Medical LLC NanoHive Medical is a pioneer and leading innovator in 3D printed spinal interbody fusion implants and instrumentation. The company's proprietary, biomimetic Soft Titanium® technology clearly distinguishes their products in the $2.4B U.S. spinal interbody fusion device market. The Hive™ portfolio of interbody fusion devices provide surgeons and their patients ideal biomechanical elastic modulus properties, clear and precise diagnostic imaging capability, osteoblast cell attraction and integration – all features that lead to consistently strong fusion constructs and efficacious clinical experiences. NanoHive Medical is based in Woburn, Massachusetts U.S.A. Contact: Patrick O'Donnell, CEO & President, NanoHive Medical LLC, Website: About DirectSync Surgical DirectSync Surgical is a rising leader in smart patient powered implant devices. With a commitment to innovation and foundational research, the company develops and manufactures advanced tools that empower both spinal and orthopedic professionals to achieve superior surgical outcomes. DirectSync Surgical's products are not available for sale in the US. Contact: Leighton LaPierre, COO, DirectSync Surgical, leighton@ Website: NanoHive Medical, LLC | 12 Gill Street, Suite 4500 | Woburn, MA 01801 | 844-943-5433 View original content to download multimedia: SOURCE NanoHive Medical Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 minutes ago
- Yahoo
New IBO Survey Reveals Major Cuts to Lab Budgets Amid NIH Grant Terminations
ARLINGTON, Va., June 10, 2025 /PRNewswire/ -- A new survey conducted by Instrument Business Outlook (IBO) has uncovered significant reductions in laboratory budgets across the U.S. academic and government research landscape, with lab product spending sharply impacted by recent NIH grant terminations. The findings, based on an exclusive IBO survey, shed light on the growing financial uncertainty facing scientific research labs in 2025. The results follow widespread disruptions in NIH funding, with more than 1,500 grants totaling $7.5 billion terminated as of May 20, according to data from Grant Watch. While the exact numbers remain fluid due to inconsistent reporting by federal agencies, the toll is undeniable: R01 research grants—a cornerstone of basic research—have been particularly hard-hit, with 322 grants worth nearly $790 million terminated. "The fallout from NIH funding changes is cascading through the research ecosystem," said Tanya Samazan, Editor-In-Chief. "Our survey shows just how deeply this uncertainty is affecting labs—from basic research to clinical trial infrastructure." Survey Highlights: Budget Cuts Across the Board Conducted by the Science Advisory Board (SAB) between mid- and late May, the survey collected 117 responses from U.S.-based labs, with 88 indicating their labs were impacted by NIH-related funding disruptions. Key findings include: 59% of labs report direct impacts from NIH-related grant or contract terminations, delays, or reductions. 47% report indirect impacts. Among affected labs, nearly 60% have reduced 2025 operating budgets by more than 10%. 51% report capital budget reductions exceeding 10%. When excluding labs that were uncertain or unaffected, the scale becomes even more dramatic: 71% of labs report operating budget cuts of over 10%. 71% report similar reductions in capital budgets. Lab Tools and Consumables Hit Hardest Every category of lab spending has been affected, according to survey data: 80% of labs have reduced their 2025 consumables budgets, making it the most impacted category. 63% have cut software/informatics budgets. 70% have reduced spending on devices under $50,000. Even high-end instrumentation (>$150,000) hasn't been spared, with 62% of labs trimming these budgets. Institutes Most Affected The survey findings align with NIH grant termination data indicating the hardest-hit institutions include: National Institute of Mental Health, with over $400 million in losses. National Institute of General Medical Sciences, which lost the highest number of grants (134). Institutes heavily reliant on lab instruments, including the National Institute of Biomedical Imaging and Bioengineering and the National Human Genome Research Institute. Medical schools and hospitals have borne a significant share of the burden, accounting for 50% of terminated grants and 55% of total terminated NIH dollars. A Shifting Landscape with No Clear Path Forward The rapidly evolving nature of NIH decisions—including ongoing terminations and reinstatements—has created a volatile funding environment. Labs are being forced to make difficult decisions with limited visibility into future funding. About Instrument Business Outlook (IBO)IBO is a leading newsletter providing market intelligence for the analytical instrument industry. Published by Strategic Directions International (SDi), a division of Science and Medicine Group, IBO offers in-depth coverage of technology, business, and market trends affecting the life sciences and lab tools sectors. View original content to download multimedia: SOURCE Instrument Business Outlook Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 minutes ago
- Yahoo
Shutterstock Receives Stockholder Approval for Proposed Merger with Getty Images
NEW YORK, June 10, 2025 /PRNewswire/ -- Shutterstock, Inc. (NYSE: SSTK) ("Shutterstock"), a leading global creative platform offering high-quality creative content for transformative brands, digital media and marketing companies, today announced that Shutterstock's stockholders approved the adoption of the merger agreement between Shutterstock and Getty Images Holdings, Inc. (NYSE: GETY) ("Getty Images"), with approximately 82% of the issued and outstanding shares of Shutterstock common stock voting in favor, at today's special meeting of Shutterstock stockholders. Stockholder approval marks an important milestone in the process of combining Shutterstock and Getty Images to create a premier visual content company. The combined company will be well-positioned to meet the ever-changing needs of customers through combined investment in content creation, event coverage, and product and technology innovation. "We are very pleased that our stockholders recognize the compelling rationale of this transaction and look forward to the successful completion of our merger with Getty Images," said Paul Hennessy, Shutterstock's Chief Executive Officer. "Our complementary strengths will allow us to better serve customers while also delivering exceptional value to our partners, contributors and stockholders in a fast evolving and competitive environment." Both parties continue to expect the transaction to close in the second half of 2025, subject to required regulatory approvals and other customary conditions. The final voting results will be reported on a Form 8-K filed with the Securities and Exchange Commission. ABOUT SHUTTERSTOCKShutterstock, Inc. (NYSE: SSTK) is a leading global creative platform offering high-quality creative content for transformative brands, digital media and marketing companies. Fueled by millions of creators around the world, a growing data engine and a dedication to product innovation, Shutterstock is the leading global platform for licensing from the most extensive and diverse collection of high-quality 3D models, videos, music, photographs, vectors and illustrations. From the world's largest content marketplace, to breaking news and A-list entertainment editorial access, to all-in-one content editing platform and studio production services—all using the latest in innovative technology—Shutterstock offers the most comprehensive selection of resources to bring storytelling to life. Learn more at and follow us on LinkedIn, Instagram, X, Facebook and YouTube. FORWARD-LOOKING STATEMENTSThe statements in this press release, and any related oral statements, include forward-looking statements concerning Getty Images, Shutterstock, the proposed transaction described herein and other matters. All statements, other than historical facts, are forward-looking statements. Forward-looking statements may discuss goals, intentions and expectations as to future plans, trends, events, results of operations or financial condition, financings or otherwise, based on current beliefs and involve numerous risks and uncertainties that could cause actual results to differ materially from expectations. Forward-looking statements speak only as of the date they are made or as of the dates indicated in the statements and should not be relied upon as predictions of future events, as there can be no assurance that the events or circumstances reflected in these statements will be achieved or will occur or the timing thereof. Forward-looking statements can often, but not always, be identified by the use of forward-looking terminology including "believes," "expects," "may," "will," "should," "could," "might," "seeks," "intends," "plans," "pro forma," "estimates," "anticipates," "designed," or the negative of these words and phrases, other variations of these words and phrases or comparable terminology, but not all forward-looking statements include such identifying words. Forward-looking statements are based upon current plans, estimates and expectations that are subject to risks, uncertainties and assumptions. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary. The forward-looking statements in this press release relate to, among other things, obtaining applicable regulatory approvals for the proposed transaction on a timely basis or otherwise, satisfying other closing conditions to the proposed transaction, on a timely basis or otherwise, the expected tax treatment of the proposed transaction, the expected timing of the proposed transaction, and the integration of the businesses and the expected benefits, cost savings, accretion, synergies and growth to result therefrom. Important factors that could cause actual results to differ materially from the forward-looking statements include, among other things: failure to obtain applicable regulatory approvals in a timely manner or otherwise; interloper risk; failure to satisfy other closing conditions to the transaction or to complete the transaction on anticipated terms and timing (or at all); negative effects of the announcement of the transaction on the ability of Shutterstock or Getty Images to retain and hire key personnel and maintain relationships with customers, suppliers and others who Shutterstock or Getty Images does business, or on Shutterstock or Getty Images' operating results and business generally; risks that the businesses will not be integrated successfully or that the combined company will not realize expected benefits, cost savings, accretion, synergies and/or growth, as expected (or at all), or that such benefits may take longer to realize or may be more costly to achieve than expected; the risk that disruptions from the transaction will harm business plans and operations; risks relating to unanticipated costs of integration; significant transaction and/or integration costs, or difficulties in connection with the transaction and/or unknown or inestimable liabilities; restrictions during the pendency of the transaction that may impact the ability to pursue certain business opportunities or strategic transactions; potential litigation associated with the transaction; the potential impact of the announcement or consummation of the transaction on Getty Images', Shutterstock's or the combined company's relationships with suppliers, customers, employers and regulators; demand for the combined company's products; potential changes in the Getty Images stock price that could negatively impact the value of the consideration offered to the Shutterstock stockholders; the occurrence of any event that could give rise to the termination of the proposed transaction; and Getty Images' ability to complete any refinancing of its debt or new debt financing on a timely basis, on favorable terms or at all. A more fulsome discussion of the risks related to the proposed transaction is included in the information statement and proxy statement/prospectus filed with the SEC by Shutterstock and Getty Images in connection with the proposed transaction. For a discussion of factors that could cause actual results to differ materially from those contemplated by forward-looking statements, see the section captioned "Risk Factors" in each of Getty Images' and Shutterstock's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, subsequent Quarterly Reports on Form 10-Q and other filings with the SEC. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward looking statements. While the list of factors presented here is, and the list of factors presented in the information statement and proxy statement/prospectus filed with the SEC by Shutterstock and Getty Images in connection with the proposed transaction is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward looking statements. Neither Getty Images nor Shutterstock assumes, and each hereby disclaims, any obligation to update forward-looking statements, except as may be required by law. View original content to download multimedia: SOURCE Shutterstock, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data